Position in PCRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$885,210
+$217,697 QoQ
Shares Held
34,892
+18.1% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#96
of 254 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SEGALL BRYANT & HAMILL, LLC holds $61,046,740 across 14 Drug Manufacturers - Specialty & Generic names. PCRX ranks #12 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
498,222 | $26,106,832 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
64,908 | $10,939,594 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
71,901 | $4,598,068 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
240,060 | $4,155,438 | |
| 5 | LQDA |
Liquidia Corp
|
50,802 | $4,050,443 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
32,860 | $2,720,150 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
408,064 | $1,717,949 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
25,931 | $1,206,050 |
All Filings in PCRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $885,210 | 34,892 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $667,513 | 29,536 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $764,391 | 29,536 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $764,930 | 29,683 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $711,383 | 29,765 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $792,342 | 31,885 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $604,029 | 32,061 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $482,518 | 32,061 | Shares | Sole | 2024-11-08 | |
| 2023-09-30 | $4,231,539 | 137,925 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,784,371 | 94,444 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,838,058 | 94,047 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,586,174 | 92,882 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,598,488 | 86,454 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,940,516 | 84,743 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,553,632 | 59,665 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,581,077 | 59,516 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,177,664 | 56,744 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $3,715,679 | 61,234 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $4,101,106 | 58,512 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $3,516,856 | 58,771 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,592,049 | 59,748 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,087,703 | 20,730 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $679,954 | 20,279 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||